source
- Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billionEli Lilly has signed a partnership agreement with Beijing-based InnoCare to co-develop new medicines. InnoCare will apply its internal drug discovery platform while Lilly will contribute its devel…
- FDA warns Houston compounding pharmacy of unsanitary GLP-1 production risking contaminationFDA issued a warning letter to Empower Clinic Services, operating as Empower Pharmacy, after inspectors found unsanitary conditions at its Houston compounding site. Inspectors observed that the ph…